Idiopathic thrombocytopenic purpura and dysmegakaryocytopoiesis

Critical Reviews in Oncology/Hematology

Volumn 64, Issue 2, 2007, Pages 83-89

  Wang, Lin ^a   Li, Yuan ^a   Hou, Ming ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Autoantibody; Idiopathic thrombocytopenic purpura; Megakaryocyte; Platelet

Indexed keywords

IMMUNOGLOBULIN; INTERLEUKIN 11; INTERLEUKIN 3; INTERLEUKIN 6; PREDNISONE; STEM CELL FACTOR; THROMBOCYTE ANTIBODY; THROMBOPOIETIN;

APOPTOSIS; AUTOIMMUNE DISEASE; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MEGAKARYOPOIESIS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; REVIEW; T LYMPHOCYTE; THROMBOCYTE COUNT; THROMBOCYTE LIFESPAN; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

BLOOD PLATELETS; CYTOKINES; HUMANS; MEGAKARYOCYTES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; THROMBOCYTOPENIA; THROMBOPOIESIS;

EID: 34748916337     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2007.05.007     Document Type: Review

References (62)

1. Coopamah M.D., Garvey M.B., Freedman J., et al. Cellular immune mechanisms in autoimmune thrombocytopenic purpura: an update. Transfus Med Rev 17 (2003) 69-80
2. Olsson B., Andersson P.O., Jernas M., et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 9 (2003) 1123-1124
3. Zhang F., Chu X., Wang L., et al. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura. Eur J Haematol 76 (2006) 427-431
4. Ballem P.J., Segal G.M., Stratton J.R., et al. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 80 (1987) 33-40
5. Stoll D., Cines D.B., Aster R.H., et al. Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood 65 (1985) 584-588
6. Diggs L.W., and Hewlett J.S. A study of the bone marrow from thirty-six patients with idiopathic hemorrhagic (thrombopenic) purpura. Blood 3 (1948) 1090-1104
7. Ridell B., and Branehög I. The ultrastructure of the megakaryocytes in idiopathic thrombocytopenic purpura (ITP) in relation to thrombokinetics. Pathol Eur 11 (1976) 179-187
8. Jackson C.W. Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood 42 (1973) 413-421
9. Rabellino E.M., Levene R.B., Leung L.L., et al. Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes. J Exp Med 154 (1981) 88-100
10. Gewirtz A.M. Megakaryocytopoiesis: the state of the art. Thromb Haemost 74 (1995) 204-209
11. Italiano Jr. J.E., Lecine P., Shivdasani R.A., et al. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 147 (1999) 1299-1312
12. Hartwig J., and Italiano Jr. J.E. The birth of the platelet. J Thromb Haemost 1 (2003) 1580-1586
13. Patel S.R., Hartwig J.H., and Italiano Jr. J.E. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 115 (2005) 3348-3354
14. Kuter D.J., Beeler D.L., and Rosenberg R.D. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 91 (1994) 11104-11108
15. Kaushansky K., Lok S., Holly R.D., et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369 (1994) 568-571
16. Broudy V.C., Lin N.L., and Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 85 (1995) 1719-1726
17. Norol F., Vitrat N., Cramer E., et al. Effects of cytokines on platelet production from blood and marrow CD34+ cells. Blood 91 (1998) 830-843
18. Hou M., Andersson P.O., Stockelberg D., et al. Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes. Br J Haematol 101 (1998) 420-424
19. Cremer M., Schulze H., Linthorst G., et al. Serum levels of thrombopoietin, IL-11, and IL-6 in pediatric thrombocytopenias. Ann Hematol 78 (1999) 401-417
20. Haznedaroglu I.C., Buyukasik Y., Kosar A., et al. Selectins and IL-6 during the clinical course of idiopathic thrombocytopenic purpura. Acta Haematol 101 (1999) 16-20
21. Porcelijn L., Folman C.C., Bossers B., et al. The diagnostic value of thrombopoietin level measurements in thrombocytopenia. Thromb Haemost 79 (1998) 1101-1105
22. Debili N., Wendling F., Cosman D., et al. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 85 (1995) 39l-401
23. Gouin-Thibault I., Cassinat B., Chomienne C., et al. Is the thrombopoietin assay useful for differential diagnosis of thrombocytopenia? Analysis of a cohort of 160 patients with thrombocytopenia and defined platelet life span. Clin Chem 47 (2001) 1660-1665
24. Sakane Y., Wada H., Kazuyo H., et al. Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy. Blood Coagul Fibrinolysis 9 (1998) 315-321
25. Harker L.A., Marzec U.M., Hunt P., et al. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Blood 88 (1996) 511-521
26. Nomura S., Dan K., Hotta T., et al. Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura. Blood 100 (2002) 728-730
27. Bussel J.B., Kuter D.J., George J.N., et al. AMG, 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 355 (2006) 1672-1681
28. Bussel J.B., Mukherjee R., and Stone A.J. A pilot study of rhu-IL 11 treatment of refractory ITP. Am J Hematol 66 (2001) 172-177
29. de Alarcon P.A., Mazur E.M., and Schmieder J.A. In vitro megakaryocytopoiesis in children with acute idiopathic thrombocytopenic purpura. Am J Pediatr Hematol Oncol 9 (1987) 212-218
30. Sugiyama H., Yagita M., Takahashi T., et al. Megakaryocytopoiesis in idiopathic thrombocytopenic purpura. Nippon Ketsueki Gakkai Zasshi 50 (1987) 119-128
31. Abgrall J.F., Berthou C., Sensebe L., et al. Decreased in vitro megakaryocyte colony formation in chronic idiopathic thrombocytopenic purpura. Br J Haematol 85 (1993) 803-804
32. Dan K., Gomi S., and Nomura T. Kinetics of megakaryocyte progenitor cells in idiopathic thrombocytopenic purpura. Blut 61 (1990) 303-306
33. Xue M., Deng C.Q., Meng W.T., et al. Study on growth and maturation of megakaryocyte progenitors in vitro in patients with chronic idiopathic thrombocytopenic purpura. J Exp Hematol 9 (2001) 52-55
34. Hoffman R., Mazur E., Bruno E., et al. Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies. N Engl J Med 305 (1981) 533-538
35. Bellucci S., Han Z.C., and Caen J.P. Studies of in vitro megakaryocytopoiesis in adult immune thrombocytopenic purpura (ITP). Eur J Haematol 47 (1991) 86-90
36. Craddock Jr. C.G., Adams W.S., Perry S., et al. The dynamics of platelet production as studied by a depletion technique in normal and irradiated dogs. J Lab Clin Med 45 (1955) 906-919
37. Pisciotta A.V., Stefanini M., and Dameshek W. Studies on platelets. X. Morphologic characteristics of megakaryocytes by phase contrast microscopy in normals and in patients with idiopathic thrombocytopenic purpura. Blood 8 (1953) 703-723
38. Houwerzijl E.J., Blom N.R., de Wolf J.T., et al. Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood 103 (2004) 500-506
39. Vainchenker W., Deschamps J.F., Bastin J.M., et al. Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in vivo cells from normal and leukemia patients. Blood 59 (1982) 514-521
40. McMillan R., Luiken G.A., Levy R., et al. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA 239 (1978) 2460-2462
41. Stahl C.P., Zucker-Franklin D., and McDonald T.P. Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP. Blood 67 (1986) 421-428
42. Hoffman R., Zaknoen S., Yang H.H., et al. An antibody cytotoxic to megakaryocyte progenitor cells in a patient with immune thrombocytopenic purpura. N Engl J Med 312 (1985) 1170-1174
43. Nagasawa T. Immunological approaches to normal and abnormal megakaryopoiesis-effects of monoclonal antibody and autoantibody against platelet glycoprotein IIb/IIIa on the growth of megakaryocytic progenitors. Nippon Ketsueki Gakkai Zasshi 50 (1987) 1723-1729
44. Leven R.M., and Tablin F. Extracellular matrix stimulation of guinea pig megakaryocyte proplatelet formation in vitro is mediated through the vitronectin receptor. Exp Hematol 20 (1992) 1316-1322
45. Leven R.M. Differential regulation of integrin-mediated proplatelet formation and megakaryocyte spreading. J Cell Physiol 163 (1995) 597-607
46. Takahashi R., Sekine N., and Nakatake T. Influence of monoclonal antiplatelet glycoprotein antibodies on in vitro human megakaryocyte colony formation and proplatelet formation. Blood 93 (1999) 1951-1958
47. Chang M., Nakagawa P.A., Williams S.A., et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 102 (2003) 887-895
48. McMillan R., Wang L., Tomer A., et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 103 (2004) 1364-1369
49. Arnold D.M., Dentali F., Crowther M.A., et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 146 (2007) 25-33
50. Parodi E., Nobili B., Perrotta S., et al. Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment. Int J Hematol 84 (2006) 48-53
51. Cooper N., and Bussel J. The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol 133 (2006) 364-374
52. Zauli G., Vitale M., Falcieri E., et al. In vitro senescence and apoptotic cell death of human megakaryocytes. Blood 90 (1997) 2234-2243
53. De Botton S., Sabri S., Daugas E., et al. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 100 (2002) 1310-1317
54. Kaluzhny Y., and Ravid K. Role of apoptotic processes in platelet biogenesis. Acta Haematol 111 (2004) 67-77
55. Battinelli E., and Loscalzo J. Nitric oxide induces apoptosis in megakaryocytic cell lines. Blood 95 (2000) 3451-3459
56. Battinelli E., Willoughby S.R., Foxall T., et al. Induction of platelet formation from megakaryocytoid cells by nitric oxide. Proc Natl Acad Sci USA 98 (2001) 14458-14463
57. Kim J.A., Jung Y.J., Seoh J.Y., et al. Gene expression profile of megakaryocytes from human cord blood CD34+ cells ex vivo expanded by thrombopoietin. Stem Cells 20 (2002) 402-416
58. Bouillet P., Metcalf D., Huang D.C., et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286 (1999) 1735-1738
59. Kaluzhny Y., Yu G., Sun S., et al. BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation. Blood 100 (2002) 1670-1678
60. Ogilvy S., Metcalf D., Print C.G., et al. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci USA 96 (1999) 14943-14948
61. Ucar C., Oren H., Irken G., et al. Investigation of megakaryocyte apoptosis in children with acute and chronic idiopathic thrombocytopenic purpura. Eur J Haematol 70 (2003) 347-352
62. Houwerzijl E.J., Blom N.R., van der Want J.J., et al. Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death. Leukemia 20 (2006) 1937-1942